MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Surgical Technology_Gastrointestinal_GI
Previse
Organization & Developments: Previse
Parents
Previse
Children
*Previse is a gastrointestinal health company with a primary focus on chronic acid reflux related diseases, including esophageal cancer.
*Previse leverages groundbreaking biomarker technology developed by Stephen Meltzer, M.D., and his GI Early Detection Biomarker Lab at the Johns Hopkins University School of Medicine.
2024: PREVISE RECEIVES $1.8M RESEARCH GRANT FROM THE NATIONAL INSTITUTES OF HEALTH TO FURTHER PIPELINE DIAGNOSTIC TEST
2024: Previse Showcases New Data Highlighting Clinical Utility of Esopredict® Barrett's Esophagus Prognostic Test at ACG 2024
Jumps
Finance & Acquisition: Previse
Key People: Previse